Trial intelligence / Profile preview

Astagraf XL vs Immediate-Release Tacrolimus in Kidney Transplant

NCT02723591Phase 4Completed

Sponsor
Astellas Pharma
Start
Sep 2016
Primary completion
Jun 2019
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by Astellas Pharma. Started Sep 2016; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT02723591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02723591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call